No current evidence supporting risk of using Ibuprofen in patients with COVID-19
- PMID: 32506743
- PMCID: PMC7300561
- DOI: 10.1111/ijcp.13576
No current evidence supporting risk of using Ibuprofen in patients with COVID-19
Conflict of interest statement
None.
Comment on
-
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11. Lancet Respir Med. 2020. PMID: 32171062 Free PMC article. No abstract available.
References
-
- Krenke K, Krawiec M, Kraj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community‐acquired pneumonia. Clin Respir J. 2018;12:253‐261. - PubMed
-
- François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010;99:861‐866. - PubMed
-
- Qiao W, Wang C, Chen B, et al. Ibuprofen attenuates cardiac fibrosis in streptozotocin‐induced diabetic rats. Cardiology. 2015;131:97‐106. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical